Misconceptions about lung cancer, such as the stigma of smoking, are addressed, highlighting that anyone with lungs can ...
Prostate cancer survivor Mick Barrett is calling on businesses to consider installing rubbish bins inside men's bathrooms to ...
“PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of ...
Merck says Keytruda plus Padcev improved survival and response rates versus chemotherapy in a Phase 3 muscle-invasive bladder ...
A combination of the antibody-drug conjugate enfortumab vedotin (Padcev) and the PD-1 inhibitor pembrolizumab (Keytruda) ...
The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the ...
Armed with new three-year data demonstrating the benefits of Anktiva in a specific patient subset, ImmunityBio is proving its bladder cancer med is still one to watch as it competes with heavy hitt | ...
Merck, Pfizer and Astellas, which in August reported similar results from a Phase 3 study of the combination in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based ...
Pfizer (PFE) stock is in focus as the firm with Astellas (ALPMF) post a Phase 3 trial win for Padcev cancer drug when used ...
ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...
Providing surgeons feedback and education on their performance significantly improved the quality of bladder cancer ...
6don MSN
After 7 years on dialysis, his life was transformed by the world's first ever bladder transplant
Since then, Dr. Nassiri and Inderbir Gill, MD, chair of the department of urology at USC Keck School of Medicine, had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback